Sanjay Makhija,
CEO, Biogene India
When determined and assiduous entrepreneurs endeavor rigidly from the scratch, meager investments multiply in no time. This is best exemplified by the energetic and magnetic Mr. Sanjay Makhija, the steerer of the Rs. 8 crore Biogene India that he founded in 1995 with an investment of Rs. 2 lakh. The ISO 9001: 2008 certified company is a distributor of life science research, pharma, and R&D products of leading companies of the world. “We are ranked amongst the best in our industry segment for quality and excellence. We have over 30 plus sub-distributors across the country and have been witnessing an annual growth rate of 15%,” says the charismatic Mr. Sanjay Makhija, CEO; he is backed by several years of tech-rich experience in the life sciences, pharma R&D segment.
Product Portfolio
• Life Science research products
• Pharma R&D products. “We import our products from America, South Korea, China, Canada, Ukraine and Japan,” says Mr. Makhija, who strongly believes in ethics. Mr. Makhija has been attending meeting and conferences conducted by major companies in different locations like USA, China, Vienna, Singapore, Malaysia, South Korea and Greece. Biogene India boasts of a rich client portfolio. Few of the clients include AIIMS, NCBS, IISC, DU, JNU, Glenmark, Advenus, DIACHI, NII, ICGEB, etc. and the list goes on. “We have retained 90% of our clients,” says Mr. Makhija. The group has been conferred with numerous honors and certifications over the past years; worth mentioning is BD Bio Science Distributors award. The dynamic Mr. Makhija was associated with numerous big names of the industry like Glaxo Pharma, Amersham (Blue Star for 10 years), and prior to starting Biogene India. He was honored for best sales during his stint with Blue Star Ltd. (Amersham Inc.). Mr. Makhija, who believes in teamwork, owes the success of his group to the efforts of his team. He leaves a message for the readers – “I believe in 3P’s. People are the most important then Products and then Profits follow later.”